As of 2026-11-07, the Intrinsic Value of Roche Bobois SA (RBO.PA) is 19.16 EUR. This RBO.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 15.55 EUR, the upside of Roche Bobois SA is 23.20%.
The range of the Intrinsic Value is 11.85 - 32.71 EUR
Based on its market price of 15.55 EUR and our intrinsic valuation, Roche Bobois SA (RBO.PA) is undervalued by 23.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 11.85 - 32.71 | 19.16 | 23.2% |
| DCF (Growth 10y) | 12.23 - 31.26 | 18.93 | 21.7% |
| DCF (EBITDA 5y) | 11.06 - 16.58 | 13.73 | -11.7% |
| DCF (EBITDA 10y) | 13.23 - 20.29 | 16.56 | 6.5% |
| Fair Value | 10.33 - 10.33 | 10.33 | -33.59% |
| P/E | 12.47 - 18.01 | 14.09 | -9.4% |
| EV/EBITDA | 10.86 - 41.23 | 24.30 | 56.2% |
| EPV | 114.33 - 162.32 | 138.33 | 789.6% |
| DDM - Stable | 5.40 - 11.82 | 8.61 | -44.6% |
| DDM - Multi | 7.62 - 13.51 | 9.79 | -37.0% |
| Market Cap (mil) | 157.52 |
| Beta | 0.72 |
| Outstanding shares (mil) | 10.13 |
| Enterprise Value (mil) | 309.14 |
| Market risk premium | 5.82% |
| Cost of Equity | 8.68% |
| Cost of Debt | 4.60% |
| WACC | 5.58% |